Therapeutic application of cell microencapsulation in cancer.
Although cell encapsulation technologies were originally developed for the treatment of acquired and genetic diseases such as diabetes, they can also be applied to the treatment of a variety of solid tumours. There are a number of strategies aimed at treating tumours with encapsulated cells and most of these are reviewed in this chapter. Many of these strategies have shown promise in preclinical studies and clinical trials.
Salmons
Brian
B
Austrianova Singapore Pte Ltd., 20 Biopolis Way #05-518 Centros Singapore 138668, Singapore. salmons@sgaustria.com
Gunzburg
Walter H
WH
D020533:Angiogenesis Inhibitors / Q000378:metabolism / Q000627:therapeutic use; D000818:Animals; D000906:Antibodies / Q000378:metabolism / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000378:metabolism / Q000627:therapeutic use; D002460:Cell Line; D017690:Cell Transplantation; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000378:metabolism / Q000627:therapeutic use; D004339:Drug Compounding; D016503:Drug Delivery Systems; D005822:Genetic Vectors; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D012190:Retroviridae / Q000235:genetics / Q000378:metabolism
D020533:Angiogenesis Inhibitors; D000906:Antibodies; D000970:Antineoplastic Agents; D016207:Cytokines